Upstream Bio, Inc. (UPB)
9.13
+0.04
(+0.44%)
USD |
NASDAQ |
May 11, 16:00
9.13
0.00 (0.00%)
After-Hours: 19:34
Upstream Bio Market Cap : 496.85M for May 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.95B |
| Regeneron Pharmaceuticals, Inc. | 74.70B |
| Janux Therapeutics, Inc. | 867.20M |
| Evommune, Inc. | 834.91M |
| ACADIA Pharmaceuticals, Inc. | 3.734B |
Market Cap Related Metrics
| PS Ratio | 172.41 |
| PEG Ratio | -0.0147 |
| Price to Book Value | 1.462 |
| Price | 9.13 |
| Earnings Yield | -29.17% |
| PEGY Ratio | -0.0147 |